Background and Purpose-The relationship between alcohol consumption and stroke appears complex; moderate ingestion is associated with reduced stroke risk, while heavy intake is associated with increased stroke risk. Ethanol has been shown both experimentally and epidemiologically to induce hemorrhagic and ischemic strokes, which are associated with cerebral vasoconstriction. Ethanol is known to induce contraction in isolated cerebral arteries and intact microvessels from diverse mammalian animals. The relationships between ethanol-induced contractions in cerebral arteries, intracellular free Ca 2ϩ ([Ca 2ϩ ] i ), tyrosine kinases (including the src family), and mitogen-activated protein kinases (MAPK) were investigated in the present study. 
lthough it is believed that moderate alcohol intake, 1 especially moderate wine intake, 2 may exert cardioprotective action, numerous studies over the past 2 decades have affirmed that the risk for developing cerebral vascular diseases, such as stroke, clearly increases with increasing alcohol consumption. [3] [4] [5] Recent observations of the in situ cerebral microcirculation and a variety of isolated mammalian cerebral arteries indicate that acute treatment with ethanol produces prolonged constrictions in cerebral blood vessels, [5] [6] [7] [8] suggesting that such vasoconstrictive actions of ethanol are involved in the hypoxic, ischemic, and hemorrhagic actions of alcohol in the brain. Support for the latter concept derives from recent studies of ethanol-induced stroke in intact animals See Editorial Comment, page 257 using 31 P nuclear magnetic resonance and reflectance spectroscopy to follow in vivo changes in brain bioenergetics, blood flow, and blood volume. 9, 10 Except for Mg 2ϩ or selective antioxidants, nothing else is known to either ameliorate or prevent experimentally induced alcohol-induced strokes. [11] [12] [13] Multiple signaling pathways may participate in mechanisms of peripheral vasoconstriction. Protein tyrosine kinases have been suggested to be important signal transduction pathways in the regulation of tone and intracellular free Ca 2ϩ ([Ca 2ϩ ] i ) in vascular smooth muscle. 14 Activated and autophosphorylated receptor tyrosine kinases recruit src homol-ogy 2 (SH2) domain-containing adaptor proteins and play a role in agonist-induced activation of Ras. 15 The mitogen-activated protein kinase kinase (MAPKK), or MEK (a cytosolic nonreceptor protein kinase), is in the family of tyrosine kinases. 16 Mitogen-activated protein kinases (MAPK), substrates of MAPKK, known as extracellular signal-regulated kinases, serve to relay, amplify, and integrate diverse signals, thus allowing a cell to coordinate a physiological response. Several observations raise the possibility that activation of tyrosine kinase might be involved in ethanol-induced constriction in gastric smooth muscle, 17 and ethanol might induce a stimulation of MAPK in aortic smooth muscle. 18 However, there is no direct evidence that tyrosine kinases or MAPK are associated with ethanol-induced cerebral vasoconstriction.
The mechanisms underlying ethanol-induced contraction of cerebral vascular smooth muscle and stroke remain less well understood. With these points in mind, we designed our present study to test the hypothesis that the contractile effects of ethanol on cerebral arteries are due, in large measure, to activation of protein tyrosine kinases, recruitment of SH2 domain adaptor proteins, and activation of MAPK and that recruitment of these enzyme pathways collectively results in modulation of [Ca 2ϩ ] i .
Materials and Methods

General Procedures
Rings of canine basilar arteries were obtained from male mongrel dogs (weight, 18 to 22 kg), after administration of pentobarbital sodium anesthesia (40 mg/kg IV), as described previously, 8 25 . 19 The rings were 3 to 4 mm in length. The endothelium was denuded as described previously, 8 and the denuded endothelium rings precontracted with prostaglandin F 2␣ (PGF 2␣ ) failed to relax Ͼ10% to maximal concentrations of substance P. 8 The segments were mounted on stainless steel pins under 2 g resting tension in isolated organ baths, attached to force transducers (Grass model FT 03), and connected to Grass model 7 polygraphs. The organ baths, containing normal Krebs-Ringer bicarbonate solution, were gassed continuously with 95% O 2 and 5% CO 2 and warmed to 37°C (pH 7.4). Tissues were allowed to equilibrate for at least 90 minutes before data collection. At the beginning of an experiment, rings were exposed for 30 to 45 minutes to 80 mmol/L KCl, and this was repeated every 30 to 45 minutes, until responses were stable (2 to 3 times). When tissues were pretreated by various drugs, the drug was applied for at least 15 minutes before the concentration-response curves were obtained. All of the animal experimental procedures were approved by our institutional animal care and use committee.
Intracellular Ca 2؉ Measurement
Primary smooth muscle cells from canine basilar arteries for image analysis experiments were seeded on glass coverslips (12 mm diameter; approximately 1ϫ10 4 cells per coverslip) and used 2 to 3 days after seeding, as described in the literature. 20 Monolayers of the smooth muscle cells, grown on the coverslips, were loaded with 2.0 mol/L fura 2-AM and 0.12% pluronic acid F-127 (60 minutes, 37°C), and the experimental procedures for [Ca 2ϩ ] i measurements were performed as described previously using fura 2-AM. 20 The resulting images were then used to calculate [ 
Results
Ethanol-Induced Vasoconstrictions Are Inhibited by a Tyrosine Kinase Antagonist and an SH2 Domain Inhibitor
To our knowledge, 20 mmol/L ethanol should be considered moderate ethanol intake, because it can be found in the blood of most humans after oral ingestion of only 1 to 2 oz of ethanol, 6, 22, 23 and 90 to 200 mmol/L ethanol should be considered heavy to very heavy ethanol intake; 88 mmol/L ethanol is known to be found in the blood of humans with ethanol-induced strokelike episodes. 23 Therefore, we used a concentration range of 20 to 200 mmol/L ethanol in the present study. Although not shown, intact versus endothelium-denuded cerebral arterial rings failed to manifest any significant differences in contractile concentration-response curves to ethanol (nϭ36; PϾ0.05). Only intact vessel rings were used in the present study. As shown in Figure 1A , ethanol produces a rapid contractile response (rapid component) that is followed by a prolonged, slightly diminished stable increase in vessel tension (stable component) in intact canine basilar arterial rings. Pretreatment of intact canine basilar arteries with genistein (an antagonist of protein tyrosine kinases) or an SH2 domain inhibitor peptide, but not daidzein, an inactive homologue of genistein, 24 for 15 minutes significantly attenuates ethanol-induced contractions (both rapid and stable components) in a concentrationdependent manner ( Figure 1A Figure 2C . , and 10 Ϫ6 mol/L, respectively; preincubation time of these antagonists was 15 minutes. For B and C, each point represents the peak value and meanϮSE expressed as tension (g). nϭ7; for C, #PϽ0.05, *PϽ0.01, **PϽ0.001.
Ethanol-Induced Contractions Are Inhibited by MAPK and MAPKK Antagonists
respectively, which is in close agreement with the IC 50 values found for the reduced vasoconstriction produced by ethanol in the presence of these antagonists under the same conditions. Mean values for varying concentrations of ethanol-induced elevation in [Ca 2ϩ ] i , in the absence (control) and presence of PD-98059, SB-203580, or U0126, are shown in Figure 4C . 
Effects of Tyrosine
Discussion
The present investigation aimed to determine whether activation of tyrosine kinase (including the src family) and MAPK is associated with contractile responses of cerebral arteries to ethanol, thereby giving us some insight into the potential contribution of these 2 cellular signaling pathways to ethanol-induced cerebral vasoconstriction.
Previous studies have demonstrated that tyrosine kinase (including the src family) activation is important in several vasoconstrictor-and epidermal growth factor-induced vascular contractions. 14,28 -30 These studies provide the foundation that, in addition to their mitogenic activities, tyrosine kinase(s) and src itself may play some important roles in agonist-induced smooth muscle contraction. However, little knowledge is currently available concerning the actions of tyrosine kinases in ethanol-induced cerebral vasoconstriction.
As the present study has demonstrated, the ability of genistein (an antagonist of protein tyrosine kinase) and an SH2 domain inhibitor peptide to impair ethanol-induced contractions in canine basilar arterial segments implicates the involvement of tyrosine kinase activation (phosphorylation, including src) in the cerebrovascular contractile responses of cerebral smooth muscle to ethanol. We used daidzein, a structurally similar but inactive form of genistein, in the present study as a control agent to test the selectivity of tyrosine kinase antagonists, especially genistein. The calculated IC 50 values reported herein for genistein and the SH2 domain inhibitor peptide are in a range similar to the reported K i values of genistein for protein tyrosine kinase 24 and SH2-SH3/phosphoprotein interaction. 31 Our present findings are well supported by a recent study in which the tyrosine kinase antagonists, genistein and tyrphostin-47, were reported to inhibit the contractile action of ethanol on guinea pig gastric smooth muscle, although these data were not obtained from cerebral blood vessels. 17 The involvement of tyrosine kinase, including the src family, is reinforced by the present findings that genistein and an SH2 domain inhibitor peptide suppress both the ethanolinduced transient and sustained increments in [Ca 2ϩ ] i in single canine basilar smooth muscle cells at calculated IC 50 values, which are in good agreement with those of ethanol-induced arterial contractions under the same conditions and are consistent with previously published K i values for these 2 antagonists. 24, 31 These data suggest that contraction of the cerebral arteries to ethanol may be mediated, at least partially, by an elevation in [Ca 2ϩ ] i in canine basilar arterial smooth muscle cells modulated by activation of tyrosine kinase, including src. This conclusion gains strong support from several lines of recent experimental findings: (1) plateletderived growth factor BB elicits Ca 2ϩ influx in human cultured vascular smooth muscle cells via a tyrosine kinasedependent mechanism 32 ; (2) genistein can inhibit the activity of L-type Ca 2ϩ channels in vascular smooth muscle cells from rat portal vein 33 ; (3) serotonin-evoked Ca 2ϩ release from the sarcoplasmic reticulum in vascular smooth muscle cells is blocked by genistein 34 ; and (4) tyrosine phosphorylation by both nonreceptor and receptor tyrosine kinases could be an important mechanism by which voltage-operated channels are regulated in vascular muscle. 35, 36 Several recent studies indicate that MAPK plays important roles in diverse vasoconstrictor-induced contraction in rat cerebral arteries, rat aorta, and guinea pig gastric longitudinal smooth muscle. 28, 30, 37 These previous findings implicate the MAPK pathway in modulation of vascular smooth muscle contractility and, as a tyrosine kinase, MAPKK might be a logical candidate to be activated by ethanol stimulation. An important observation presented herein is that PD-98059 (a specific MAPKK antagonist 25 ), SB-203580 (a highly specific antagonist of p38 MAPK 26 ) , and U0126 (a potent and selective antagonist of MEK1/MEK2 27 ) produce significant concentration-dependent attenuation of ethanol-induced contractions in intact canine basilar arteries. The calculated IC 50 values for PD-98059, SB-203580, and U1026 are consistent with the reported K i values for these 3 antagonists. [25] [26] [27] These results suggest that activations of both MAPKK and MAPK pathways in cerebral arterial smooth muscle cells play important roles in these ethanol-induced contractile responses. This concept derives strong support from a very recent study that demonstrates that concentrations of ethanol (17 to 170 mmol/L) similar to those used in the present study could induce a dose-dependent stimulation of p44/p42 MAPKs in rat aortic smooth muscle cells. 18 It has been shown previously that MAPK is involved in angiotensin and low [ [25] [26] [27] These results could thus be used to support the aforementioned contention that MAPKK and MAPK are indeed important in ethanol-evoked contractile responses.
It was noted that the antagonists of tyrosine kinase and MAPK used herein produced relaxant effects (albeit much smaller effects compared with those against ethanol) on PGF 2␣ -precontracted isolated canine cerebral arteries. In our opinion, this does not indicate that the signaling pathways activated by ethanol are not specific. PGF 2␣ may contract, in part, the basilar arterial segments by activating tyrosine kinases and MAPK. Similar results have been reported by other investigators for PGF 2␣ and other vasoactive substances in other type of smooth muscle. 30, 40, 41 A variety of specific pharmacological antagonists of known endogenously formed vasoconstrictors did not inhibit or attenuate the ethanol contractions and elevation of [Ca 2ϩ ] i , which suggests no involvement or release of endogenous vasoconstrictors (ie, histamine, catecholamines, serotonin, acetylcholine, opiates, or prostanoids) in such ethanolinduced contractile actions.
In summary, several points are noteworthy regarding the potential physiological and clinical significance of our present study. First, the ethanol-induced contractions in canine cerebral arterial segments can be significantly attenuated by tyrosine kinase and MAPK antagonists. Second, concomitantly, the increase in [Ca 2ϩ ] i in single cells from canine cerebral arterial smooth muscle induced by ethanol can be suppressed by the aforementioned antagonists, also in concentrations associated with their specific inhibitory actions on their target enzymes. Overall, these results support the importance of tyrosine kinases, including the src family and MAPK pathways, to ethanol-associated cerebral vascular contraction. The present studies thus may help to shed new light on the etiologies of cerebral ischemia, cerebral vasoconstriction, and diverse cerebrovascular/stroke disease states associated with ethanol. Although ethanol-induced cerebral vasoconstriction is clearly a complicated event, the approach taken in this study may prove useful in development of prophylactic and therapeutic tools for prevention and amelioration of alcohol-induced stroke and hypertension.
Editorial Comment
Alcohol drinking and abstinence are both part of our social culture. The epidemiological relationships between alcohol drinking and stroke appear to be "U-shaped" and are a frequent source of controversy in both popular press and medical/scientific literature. Light-to-moderate alcohol consumption was recently reported to reduce overall stroke risk and risk of ischemic stroke in male physicians, 1 stimulating ongoing interest and cautions 2 about alcohol's potential health benefits. Notably, moderate alcohol consumption (frequently defined as 2 drinks per day) decreases ischemic stroke risk in elderly, multiethnic subjects of both sexes after adjustment for cardiac disease, hypertension, smoking, and diabetes. 3 Ethanol's dose-restrictive, antioxidant activity may be important in these results (for review, see Hillbom 4 ). Whether ethanol ingestion increases or decreases overall stroke or stroke subtype risk appears to be dependent not only on oral dose and formulation but also on drinking pattern (regular versus binge drinking) and the presence of alcoholinduced hypertension and proembolic changes, including thromboxane-mediated platelet activation. 5 Nevertheless, numerous studies indicate that heavy recent alcohol drinking is an independent risk factor for all major subtypes of stroke. In animals, the majority of work agrees that acute alcohol induces cerebral arterial constriction. It is to these observations that the present study of Yang et al offers pathophysiological insight and new information about the signaling pathways of ethanol in intact canine basilar artery and primary vascular smooth muscle cells. These data carefully characterize dose-response relationships within ethanol concentrations that would be expected to be pathological, not protective, in human stroke. Ethanol-induced vasoconstrictor mechanisms are not limited to tyrosine kinase and mitogenactivated protein kinase in large cerebral vessels (for review, see Altura and Altura 6 ). Future work will be tasked with determining cross-talk among controllers of calcium cycling in the cerebrovascular contractile apparatus.
